Biochemistry, Genetics and Molecular Biology
Mendelian Randomization
91%
Genetics
72%
Body Mass
66%
Blood Pressure
61%
Overall Survival
57%
Genetic Risk
50%
Pleiotropy
41%
Genome-Wide Association Study
41%
Genetic Correlation
40%
Cancer Survival
37%
Clinical Biochemistry
33%
Blood Level
33%
Triacylglycerol Level
33%
B Cell
33%
Triglyceride
33%
Gene Translocation
33%
Cyclin E1
33%
Polyploid
33%
Low-Density Lipoprotein
33%
High-Density Lipoprotein
33%
Doxorubicin
33%
Tamsulosin
33%
Cyclin-Dependent Kinase
33%
Iron-Deficiency Anemia
25%
Gene Linkage Disequilibrium
22%
Genomics
20%
Blood Lipids
16%
Gene Dosage
16%
Genetic Trait
16%
Methylation
14%
Observational Study
14%
Genetic Association
13%
Pulse Pressure
13%
Cancer Cell
12%
Population Research
11%
Lipid Level
11%
Sample Size
11%
Genotyping
8%
Single-Nucleotide Polymorphism
8%
Lipid
8%
High Risk Population
8%
down Regulation
8%
Cell Polarity
8%
Cell Adhesion
8%
Progression Free Survival
8%
Iron Deficiency
8%
Small Molecule
7%
Upregulation
7%
Diastolic Blood Pressure
6%
Systolic Blood Pressure
6%
Medicine and Dentistry
Body Mass Index
80%
Migraine
66%
Esophageal Adenocarcinoma
66%
Breast Cancer
66%
Overall Survival
53%
Mendelian Randomization Analysis
44%
Neoplasm
39%
Blood Pressure
35%
Coeliac Disease
33%
Subarachnoid Hemorrhage
33%
Genetic Risk
33%
Ovarian Cancer
33%
Non Small Cell Lung Cancer
33%
25 Hydroxyvitamin D
33%
Meta-Analysis
33%
Lung Cancer Survival
33%
Intracranial Aneurysm
33%
Doxorubicin
33%
Inflammatory Bowel Disease
33%
Magnetic Resonance Imaging
33%
Breast Screening
33%
Cancer Risk
33%
Peutz Jeghers Syndrome
33%
Malignant Neoplasm
28%
Odds Ratio
28%
Cancer
22%
Mammography
18%
Gene Dosage
16%
Cancer Diagnosis
14%
Clinical Stage
13%
Migraine without Aura
10%
Tumor Biopsy
8%
Cell Polarity
8%
Cancer Cell Line
8%
Proteus Syndrome
8%
Progression Free Survival
8%
Pulse Pressure
8%
Single Nucleotide Polymorphism
8%
down Regulation
8%
Observational Study
7%
Ulcerative Colitis
6%
Log Rank Test
6%
Cancer Prognosis
6%
Migraine with Aura
6%
Cancer Localization
6%
Survival Time
6%
UK Biobank
6%
Hazard Ratio
6%
Breast Density
6%
Intermediate Risk Population
6%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Esophageal Adenocarcinoma
66%
Non Small Cell Lung Cancer
66%
Cancer Survival
41%
Digestive System Cancer
33%
Low Density Lipoprotein
33%
25 Hydroxyvitamin D
33%
High Density Lipoprotein
33%
Triacylglycerol
33%
Coeliac Disease
33%
Migraine
33%
Inflammatory Bowel Disease
33%
Tamsulosin
33%
Abdominal Cancer
33%
Peutz Jeghers Syndrome
33%
Malignant Neoplasm
28%
Lung Cancer
16%
Observational Study
11%
Esophagus Cancer
11%
Genetic Risk
11%
Migraine without Aura
10%
Tumor Suppressor Protein
8%
Biological Marker
8%
Neoplasm
8%
Cancer Prognosis
6%
Survival Time
6%
Ulcerative Colitis
6%
Migraine with Aura
6%
Diseases
6%
